Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$211.6M
+27.8% from 2023
Prescriptions
34K
$6,288.85 per claim
Patients
6,591
3,104 prescribers
Total spending, 2024
$211.6M
$32,101.61 per patient
Medicare prescription drug plans paid $211.6M for Cabenuva in 2024, for 33,648 prescriptions and refills to 6,591 patients (up 27.8% from 2023). The average cost per claim was $6,288.85.
California had the highest Medicare cost for Cabenuva in 2024: $30.7M for 5,063 claims, followed by Florida ($27.8M).
Cyril R Gaultier, infectious disease in Palm Springs, CA, had the highest Medicare cost for Cabenuva in 2024: 301 claims costing $2.1M.
Cabenuva is made by GSK plc (GSK), listed in the Medicare spending data as Viiv Healthcare.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Cyril R Gaultier Palm Springs, CA | Infectious Disease | 301 | 65 | $2.1M |
| Alireza Farabi Las Vegas, NV | Internal Medicine | 240 | 51 | $1.6M |
| Gregory D Huhn |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,701 | 14,740 | 3,221 | $87.3M |
| 2023 | 2,530 | 25,295 | 5,075 | $165.6M |
| 2024 | 3,104 | 33,648 | 6,591 | $211.6M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 157 |
| 31 |
| $1.1M |
| Janet Grochowski San Francisco, CA | Pharmacist | 221 | 51 | $1.1M |
| Waref Azmeh Baton Rouge, LA | Infectious Disease | 157 | 28 | $991K |
| Esther Fasanmi Fort Worth, TX | Pharmacist | 156 | 33 | $991K |
| Moti N Ramgopal Fort Pierce, FL | Infectious Disease | 134 | 31 | $864K |
| Belverly J Jones Detroit, MI | Nurse Practitioner | 105 | 20 | $704K |
| Ann E Stapleton Palm Springs, CA | Internal Medicine | 93 | 17 | $638K |
| Zandraetta L Tims-Cook Atlanta, GA | Infectious Disease | 87 | 18 | $582K |
| Joseph Caperna San Diego, CA | Infectious Disease | 86 | 16 | $561K |
| Matthew Herrmann Los Angeles, CA | Internal Medicine | 82 | 17 | $526K |
| Ardis A Moe Los Angeles, CA | Family Practice | 81 | 17 | $513K |
| Philbert J Ford Tallahassee, FL | Infectious Disease | 75 | 14 | $506K |
| Mark L Tanner Atlanta, GA | Family Practice | 71 | 16 | $486K |
| Roberto Ortiz Orlando, FL | Internal Medicine | 72 | 14 | $473K |
| Kush K Patel Largo, FL | Internal Medicine | 69 | 13 | $472K |
| Mark T Watkins Philadelphia, PA | General Practice | 69 | 14 | $470K |
| Aaron M Willcott San Diego, CA | Physician Assistant | 78 | 14 | $460K |
| Jean L Haspel Atlantic City, NJ | Nurse Practitioner | 70 | 14 | $445K |
| Helen C Koenig Philadelphia, PA | Internal Medicine | 73 | 12 | $438K |
| Stephen R Adams Springfield, MO | Family Practice | 66 | 13 | $436K |
| Debra L Gase Saint Louis, MO | Nurse Practitioner | 66 | 12 | $430K |
| Amanda Wolfe Greensboro, NC | Pharmacist | 68 | 17 | $430K |
| Joseph T Lonergan San Diego, CA | Internal Medicine | 74 | 15 | $428K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Viiv Healthcare GSK | 33,649 | $211.6M |